Literature DB >> 16541143

Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials).

C Kelaidi, L Ades, S Chevret, M Sanz, A Guerci, X Thomas, S de Botton, E Raffoux, C Rayon, N Fegueux, D Bordessoule, F Rigal-Huguet, H Link, A Stoppa, A Vekhoff, S Meyer-Monard, S Castaigne, H Dombret, L Degos, P Fenaux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16541143     DOI： 10.1038/sj.leu.2404158

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  4 in total

1.  LG-362B targets PML-RARα and blocks ATRA resistance of acute promyelocytic leukemia.

Authors:  X Wang; Q Lin; F Lv; N Liu; Y Xu; M Liu; Y Chen; Z Yi
Journal:  Leukemia       Date:  2016-03-08       Impact factor: 11.528

2.  All-trans retinoic acid and late relapses in acute promyelocytic leukemia: very long-term follow-up of the North American Intergroup Study I0129.

Authors:  Dan Douer; Lynette N Zickl; Charles A Schiffer; Fredrick R Appelbaum; James H Feusner; Lois Shepherd; Cheryl L Willman; Clara D Bloomfield; Elisabeth Paietta; Robert E Gallagher; Jae H Park; Jacob M Rowe; Peter H Wiernik; Martin S Tallman
Journal:  Leuk Res       Date:  2013-03-23       Impact factor: 3.156

Review 3.  Role of Retinoic Acid-Metabolizing Cytochrome P450s, CYP26, in Inflammation and Cancer.

Authors:  Faith Stevison; Jing Jing; Sasmita Tripathy; Nina Isoherranen
Journal:  Adv Pharmacol       Date:  2015-05-27

4.  Very Late Relapse of Acute Promyelocytic Leukemia 17 Years after Continuous Remission.

Authors:  Masatoshi Sakurai; Shintaro Watanuki; Jun Kato; Risa Hashida; Yusuke Yamane; Daiki Karigane; Takayuki Mitsuhashi; Mitsuru Murata; Hironori Ueno; Tomonori Nakazato; Shinichiro Okamoto; Takehiko Mori
Journal:  Intern Med       Date:  2018-07-06       Impact factor: 1.271
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.